Fund Name | Location |
Agave Capital | Cedar Park, Texas, United States |
Aichi Bank | Aichi Prefecture, Japan, Nagoya |
Charme Capital Partners | Italy, Lombardia, Milano |
Crealize | Essen, Germany, Nordrhein-Westfalen |
EIT Urban Mobility | Barcelona, Catalonia, Spain |
Everbright | China, Hong Kong, Hong Kong Island |
Fair Ventures | Canada, Ontario, Toronto |
FortisBC | British Columbia, Canada, Surrey |
Impression Ventures | Canada, Ontario, Toronto |
Jobcloud SA | Switzerland, Zürich, Zurich |
Karst Peak Capital | China, Hong Kong, Hong Kong Island |
MI-12 Ventures | - |
Michigan Emerging Technology Fund | Lansing, Michigan, United States |
Ocean Solutions Accelerator | California, San Francisco, United States |
RFF Vest | - |
Tokio Marine Capital | Chiyoda, Japan |
ULIXE Group | Italy, Piemonte, Torino |
Zhaopin | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Frontier Medicines | $80M | 22 Feb 2024 | San Francisco, California, United States | ||
Vitalnext | 01 Jul 2013 | Leiden, South Holland, Netherlands |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Frontier Medicines | $80M | 22 Feb 2024 | San Francisco, California, United States | ||
Vitalnext | 01 Jul 2013 | Leiden, South Holland, Netherlands |